FDA - Asia Tech Wire

FDA

2021.12.31

09:25

U.S. FDA said to approve Pfizer-BioNTech COVID-19 booster for ages 12-15

Asian Tech Press (Dec 31) -- The U.S. Food and Drug Administration (FDA) plans to approve the use of Pfizer-BioNTech COVID-19 vaccine booster shot in children aged 12 to 15 next Monday, according to the New York Times, citing sources familiar with the matter.

2021.12.23

03:57

Pfizer Covid-19 Pill Receives U.S. FDA Emergency Use Authorization

Asian Tech Press (Dec 23) -- Pfizer has received emergency use authorization from the U.S. Food and Drug Administration for PAXLOVID, an oral anti-coronavirus drug manufactured by Pfizer, to treat patients with covid-19 who present with mild to moderate symptoms.

2021.12.10

10:02

U.S. FDA approves Pfizer-BioNTech COVID-19 booster for 16- and 17-year-olds

Asian Tech Press (Dec 10) -- The U.S. Food and Drug Administration (FDA) approved on Thursday a booster dose of the COVID-19 vaccine co-developed by Pfizer Inc. and German company BioNTech SE for 16- to 17-year-olds.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02